Transcat, Inc (NASDAQ:TRNS) Files An 8-K Regulation FD Disclosure
Item 7.01 Regulation FD Disclosure.
On June 15, 2017, Transcat, Inc. (the Company) posted slides to
the Investor Relations section of its website that will accompany
the Companys presentations at the Marcum MicroCap Conference on
June 15, 2017. The slides are attached to this Form 8-K as
Exhibit 99.1.
The information furnished to this Item 7.01, including Exhibit
99.1, shall not be deemed filed for purposes of Section 18 of the
Securities Exchange Act of 1934, as amended (the Exchange Act) or
otherwise subject to the liabilities under such section and shall
not be deemed to be incorporated by reference into any filing of
the Company under the Securities Act of 1933, as amended, or the
Exchange Act.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
| Exhibit No. | Description | |
| 99.1 | Slides for June 15, 2017 Marcum MicroCap Conference |
About Transcat, Inc (NASDAQ:TRNS)
Transcat, Inc. is a provider of calibration and laboratory instrument services and a distributor of professional grade test, measurement and control instrumentation. The Company conducts its business through two segments: service (Service) and distribution (Distribution). Through the Service segment, the Company offers calibration, repair, inspection, analytical qualifications, preventative maintenance and other related services, a majority of which are processed through its asset management system, CalTrak (CalTrak). Through its Distribution segment, the Company markets, sells and rents national brand instruments to customers around the globe. The Company is focused on providing its services and products to the life science industries, which include pharmaceutical, biotechnology, medical device manufacturing and other Food and Drug Administration (FDA)-regulated businesses.
